Technical Analysis for CSCI - COSCIENS Biopharma Inc.

Grade Last Price % Change Price Change
D 5.040 2.02% 0.100
CSCI closed up 2.02 percent on Friday, November 1, 2024, on 1.23 times normal volume.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 2.02%
180 Bearish Setup Bearish Swing Setup 2.02%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.02%
Oversold Stochastic Weakness 2.02%
Bullish Engulfing Bullish 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Boomer Sell Setup Bearish Swing Setup 1.82%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

COSCIENS Biopharma Inc. Description

COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Diagnostic Tests Macimorelin Parkinson's Disease Peptide Hormones Tryptamines

Is CSCI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.0
52 Week Low 4.64
Average Volume 1,625
200-Day Moving Average 0.000
50-Day Moving Average 5.641
20-Day Moving Average 5.057
10-Day Moving Average 5.006
Average True Range 0.178
RSI (14) 40.48
ADX 42.55
+DI 16.927
-DI 30.219
Chandelier Exit (Long, 3 ATRs) 4.795
Chandelier Exit (Short, 3 ATRs) 5.435
Upper Bollinger Bands 5.208
Lower Bollinger Band 4.905
Percent B (%b) 0.45
BandWidth 5.996
MACD Line -0.202
MACD Signal Line -0.260
MACD Histogram 0.058
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.250
Resistance 3 (R3) 5.227 5.133 5.215
Resistance 2 (R2) 5.133 5.080 5.145 5.203
Resistance 1 (R1) 5.087 5.047 5.110 5.110 5.192
Pivot Point 4.993 4.993 5.005 5.005 4.993
Support 1 (S1) 4.947 4.940 4.970 4.970 4.888
Support 2 (S2) 4.853 4.907 4.865 4.877
Support 3 (S3) 4.807 4.853 4.865
Support 4 (S4) 4.830